Manufacturing Mesenchymal Stromal Cells for the Treatment of Graft-versus-Host Disease: A Survey among Centers Affiliated with the European Society for Blood and Marrow Transplantation (2018)
Attributed to:
Expansion of the GMP facility for Stem Cell Therapy at Imperial College
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.bbmt.2018.07.015
PubMed Identifier: 30031938
Publication URI: http://europepmc.org/abstract/MED/30031938
Type: Journal Article/Review
Parent Publication: Biology of Blood and Marrow Transplantation
Issue: 11
ISSN: 1083-8791